The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.80
Bid: 36.60
Ask: 37.30
Change: 0.00 (0.00%)
Spread: 0.70 (1.913%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 36.80
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: Kingfisher Tops FTSE 100 On CEO Change

Wed, 10th Sep 2014 16:04

LONDON (Alliance News) - UK indices ended Wednesday broadly lower after another volatile session, as underlying concerns of an independent Scotland continue.

The FTSE 100 closed flat at 6,830.11, while the FTSE 250 was again the worst performing of the main London indices falling 0.7% to 15,672.66 and the AIM All-Share ended the day 0.2% lower at 775.61.

European stocks have ended the day lower as well with the French CAC 40 falling 0.1% and the DAX closing 0.1% lower.

At the close of trade in London, US trading was mixed, with the DJIA and the S&P 500 both trading flat and the Nasdaq Composite trading up 0.1%.

The FTSE 100 clawed back initial losses during midday trading but slumped from its intraday high in the absence of fresh economic data. This caused investors to again be subdued by the prospect of an independent Scotland.

"UK markets have recovered from their modest panic on Monday morning, but the referendum will remain the only game in town for another week to come, casting a cloud of uncertainty across UK shares," said Brenda Kelly, chief market strategist at IG.

In individual stock news, Kingfisher ended the day atop the blue-chip index after it said the head of its Castorama business in France, Veronique Laury, will take over as group chief executive before the end of the current financial year, tasked with expanding the company's online sales, integrating recent acquisitions and expanding some of its brands into new markets.

In a statement, the company said current CEO Ian Cheshire will step down by the end of the financial year in January. Cheshire told journalists that after seven years as CEO, and 17 years in the Kingfisher business, he has decided that he did not want to remain in place through the next five-year strategic plan the company has started. Kingfisher's shares closed 4.3% higher.

Barratt Developments also closed the day amongst the biggest gainers in the FTSE 100 with its shares gaining 2.8%. The housebuilder said it plans to return around GBP950 million to shareholders over the next three years, as it more than doubled its final dividend following a strong year underpinned by recovery in the UK housing market.

The company, which will drop out of the FTSE 100 on September 22, said it will pay a final dividend of 7.1 pence for the year that ended June 30, compared with 2.5 pence the year before, making a total dividend of 10.3 pence. The company paid a total dividend of 2.5 pence a year earlier. Under a special cash payment programme, Barratt hopes to make a special cash payment alongside its full-year 2015 results of GBP100 million, followed by a special cash payment of GBP125 million alongside its full-year 2016 results and a special cash payment of GBP175 million with its full-year 2017 results.

The capital return plan came as the housebuilder posted pretax of GBP390.6 million for the year to June 30, up from GBP192.0 million a year earlier, as revenue rose 21% to GBP3.16 billion from GBP2.60 billion.

Thursday's economic calendar brings Europe back into focus with German consumer price index data for August being released at 0700 BST while the European Central Bank monthly report will be released at 0900 BST.

In the corporate calendar, FTSE 100-listed Next and Wm Morrison Supermarket and AIM-listed Futura Medical will release half-year results, while FTSE 250 asset manager Ashmore Group will be reporting full-year results.


By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
22 Mar 2021 09:41

BROKER RATINGS: UBS raises Rightmove to buy, Computacenter to neutral

BROKER RATINGS: UBS raises Rightmove to buy, Computacenter to neutral

Read more
22 Mar 2021 08:12

Futura Medical gets FDA OK for confirmatory study of erectile dysfunction gel

(Sharecast News) - Futura Medical shares surged on Monday after the company said it had agreed with the US Food and Drug Administration on the protocol for a small confirmatory clinical study of its erectile dysfunction gel, MED3000.

Read more
19 Mar 2021 12:26

Futura's topical erection gel recommended for EU approval

(Sharecast News) - Pharmaceuticals company Futura Medical said on Friday that the relevant EU notified body has completed the review of its technical dossier for 'MED3000', with a recommendation to certificate MED3000 as a class 2B approved medical device.

Read more
19 Mar 2021 12:06

Futura Medical shares jump as erectile dysfunction drug nears approval

Futura Medical shares jump as erectile dysfunction drug nears approval

Read more
19 Mar 2021 11:20

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

Read more
4 Mar 2021 19:32

TRADING UPDATES: Futura signs development deal; UKOG gets day in court

TRADING UPDATES: Futura signs development deal; UKOG gets day in court

Read more
4 Mar 2021 11:42

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

Read more
8 Dec 2020 17:58

IN BRIEF: Futura Medical Progresses MED3000 Regulatory Process

IN BRIEF: Futura Medical Progresses MED3000 Regulatory Process

Read more
8 Dec 2020 12:52

Futura makes solid progress on approval for erection gel

(Sharecast News) - Pharmaceutical company Futura Medical updated the market on regulatory processes and commercial activities for MED3000 - its topical gel formulation for treatment of erectile dysfunction (ED).

Read more
22 Oct 2020 14:58

UK TRADING UPDATE SUMMARY: Quartix Annual Earnings To Beat Consensus

UK TRADING UPDATE SUMMARY: Quartix Annual Earnings To Beat Consensus

Read more
16 Sep 2020 14:28

IN BRIEF: Futura Medical Loss Narrows As MED3000 Approval Nears

IN BRIEF: Futura Medical Loss Narrows As MED3000 Approval Nears

Read more
16 Sep 2020 12:44

Futura Medical narrows losses as it progresses erectile treatment

(Sharecast News) - Futura Medical reported a net loss of £1.06m in its first half on Wednesday, narrowing from a net loss of £4.46m year-on-year.

Read more
9 Sep 2020 16:00

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
10 Aug 2020 11:30

IN BRIEF: Positive QMS Opinion For Futura Medical's MED3000

IN BRIEF: Positive QMS Opinion For Futura Medical's MED3000

Read more
4 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.